Cargando…
Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
BACKGROUND: The COVID-19 pandemic has reinforced the importance of research for the health of our society and highlighted the need for stakeholders of the health research and care continuum to form a collaborative and interdependent ecosystem. OBJECTIVE: With the world still reeling from waves of th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073122/ https://www.ncbi.nlm.nih.gov/pubmed/35530174 http://dx.doi.org/10.1177/20552173221099181 |
_version_ | 1784701216723304448 |
---|---|
author | Zaratin, Paola Banwell, Brenda Coetzee, Timothy Comi, Giancarlo Feinstein, Anthony Hyde, Robert Salvetti, Marco Smith, Kathryn |
author_facet | Zaratin, Paola Banwell, Brenda Coetzee, Timothy Comi, Giancarlo Feinstein, Anthony Hyde, Robert Salvetti, Marco Smith, Kathryn |
author_sort | Zaratin, Paola |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic has reinforced the importance of research for the health of our society and highlighted the need for stakeholders of the health research and care continuum to form a collaborative and interdependent ecosystem. OBJECTIVE: With the world still reeling from waves of the COVID-19 pandemic and adapting to the vaccine rollout at widely different rates, the International Progressive MS Alliance (hereafter Alliance) organized a meeting (April 2021) to consider how the Covid-19 pandemic impacts the health and well-being of people with progressive Multiple Sclerosis (MS). METHODS: We invited the Alliance stakeholders and experts to present what they have learned about SARS-CoV-2 infection and progressive MS and to define future scientific priorities. RESULTS: The meeting highlighted three priorities for additional focus: (1) the impact of Disease Modifying Therapies (DMTs) on the risk of COVID-19 and on the efficacy of COVID-19 vaccines in people with progressive MS; (2) the long-term impact of COVID-19 and COVID-19 vaccines on the biology of progressive MS; and (3) the impact on well-being of people with progressive MS. CONCLUSION: This paper's calls to action could represent a path toward a shared research agenda. Multi-stakeholder and long-term investigations will be required to drive and evolve such an agenda. |
format | Online Article Text |
id | pubmed-9073122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-90731222022-05-07 Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance Zaratin, Paola Banwell, Brenda Coetzee, Timothy Comi, Giancarlo Feinstein, Anthony Hyde, Robert Salvetti, Marco Smith, Kathryn Mult Scler J Exp Transl Clin Future Perspectives BACKGROUND: The COVID-19 pandemic has reinforced the importance of research for the health of our society and highlighted the need for stakeholders of the health research and care continuum to form a collaborative and interdependent ecosystem. OBJECTIVE: With the world still reeling from waves of the COVID-19 pandemic and adapting to the vaccine rollout at widely different rates, the International Progressive MS Alliance (hereafter Alliance) organized a meeting (April 2021) to consider how the Covid-19 pandemic impacts the health and well-being of people with progressive Multiple Sclerosis (MS). METHODS: We invited the Alliance stakeholders and experts to present what they have learned about SARS-CoV-2 infection and progressive MS and to define future scientific priorities. RESULTS: The meeting highlighted three priorities for additional focus: (1) the impact of Disease Modifying Therapies (DMTs) on the risk of COVID-19 and on the efficacy of COVID-19 vaccines in people with progressive MS; (2) the long-term impact of COVID-19 and COVID-19 vaccines on the biology of progressive MS; and (3) the impact on well-being of people with progressive MS. CONCLUSION: This paper's calls to action could represent a path toward a shared research agenda. Multi-stakeholder and long-term investigations will be required to drive and evolve such an agenda. SAGE Publications 2022-05-03 /pmc/articles/PMC9073122/ /pubmed/35530174 http://dx.doi.org/10.1177/20552173221099181 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Future Perspectives Zaratin, Paola Banwell, Brenda Coetzee, Timothy Comi, Giancarlo Feinstein, Anthony Hyde, Robert Salvetti, Marco Smith, Kathryn Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance |
title | Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance |
title_full | Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance |
title_fullStr | Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance |
title_full_unstemmed | Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance |
title_short | Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance |
title_sort | researching covid-19 in progressive ms requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the international progressive ms alliance |
topic | Future Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073122/ https://www.ncbi.nlm.nih.gov/pubmed/35530174 http://dx.doi.org/10.1177/20552173221099181 |
work_keys_str_mv | AT zaratinpaola researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance AT banwellbrenda researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance AT coetzeetimothy researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance AT comigiancarlo researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance AT feinsteinanthony researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance AT hyderobert researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance AT salvettimarco researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance AT smithkathryn researchingcovid19inprogressivemsrequiresagloballycoordinatedmultidisciplinaryandmultistakeholderapproachperspectivesfromtheinternationalprogressivemsalliance |